Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

charles-deloye-2roumsg9rnw-unsplash

Eli Lilly partners with Ivy Tech Community College for scholarship programme

April 20, 2023 Medical Communications

Eli Lilly and Ivy Tech Community College, Indiana, US, have announced a new scholarship programme, known as Lilly Scholars @ …
News
louis-reed-pwckf7l4-no-unsplash_5

ANGLE and BioView partner to develop a CTC-based HER2 assay

April 19, 2023 Medical Communications

ANGLE, a liquid biopsy company, and BioView, a company developing, manufacturing and marketing automated microscopy imaging and analysis solutions, have …
News
mat-napo-qqyix177sy0-unsplash

FDA issues update around changes to COVID-19 vaccines’ EUAs

April 19, 2023 Medical Communications

The FDA has announced its amendment of the emergency use authorisations (EUAs) for the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA …
News
robina-weermeijer-ihfopazzjhm-unsplash_5

Neuspera Medical receives FDA approval for peripheral nerve pain system

April 19, 2023 Medical Communications

Medical device company Neuspera Medical has announced that it has received FDA approval for its implantable system, used to treat …
News

GSK enters into £1.6bn deal to acquire Bellus Health

April 18, 2023 Medical Communications

UK-based GSK has announced its plans to acquire Bellus Health, a Canadian late-stage biopharmaceutical company which focuses on treatments for …
News
nik-shuliahin-bunwp1bl0nc-unsplash

FDA approves expanded indication for AbbVie’s chronic migraine treatment

April 18, 2023 Medical Communications

US-based AbbVie has announced that the FDA has granted approval for the expanded indication of its preventative chronic migraine treatment …
News
national-cancer-institute-kluafqlacfw-unsplash

Companies showcase innovative biotech at American Association for Cancer Research

April 17, 2023 Medical Communications

Leading companies in the biotechnology sector will showcase their latest innovations at the American Association for Cancer Research (AACR) meeting …
News

Complement Therapeutics gains €72m in Series A financing for novel therapeutics research

April 17, 2023 Medical Communications

Preclinical stage biotechnology company Complement Therapeutics (CTx) has announced the completion of its Series A financing round, led by Gimv, …
News
hal-gatewood-uo7xjiv4awk-unsplash

Kala Pharmaceuticals receives FDA Fast Track Designation for human MSC-S therapy

April 13, 2023 Medical Communications

Clinical-stage biopharmaceutical company Kala Pharmaceuticals has announced that the FDA has granted it Fast Track Designation for its human mesenchymal …
News

Liberal states begin stockpiling abortion medications following Texas court ruling

April 12, 2023 Medical Communications

Various liberal US states, including California and Massachusetts, have begun stockpiling abortion medications following a Texas judge Matthew Kacsmaryk’s attempt …
News
carlos-muza-hpjsku2uysu-unsplash_1

Cognizant and Boehringer Ingelheim collaborate on integrated cloud platform to improve therapy development

April 12, 2023 Medical Communications

US-based Cognizant and biopharmaceutical company Boehringer Ingelheim have announced a partnership to collaborate on ensuring the quality, and increasing the …
News

FDA authorises marketing of MISHA Knee System for patients with knee osteoarthritis

April 11, 2023 Medical Communications

Medical device company, Moximed, has announced that the FDA granted marketing authorisation of its MISHA Knee System, an implantable shock …
News
christina-victoria-craft-whsnkiwwpec-unsplash_4

AstraZeneca’s Lynparza approved by NHS England

April 6, 2023 Medical Communications

NHS England has approved the use of AstraZeneca’s Lynparza (olaparib) for the treatment of patients with breast cancer and prostate …
News

AstraZeneca reports positive results of drug combination in late-stage ovarian cancer trial

April 5, 2023 Medical Communications

AstraZeneca has announced positive high-level results from an interim analysis of the DUO-O phase 3 trial assessing a combination of …
News
hal-gatewood-ipl3q-gegzy-unsplash_2

FDA requires prepaid mail-back envelopes for opioid analgesics

April 5, 2023 Medical Communications

The FDA has announced that it will require opioid analgesic manufacturers to provide prepaid mail-back envelopes in outpatient pharmacies and …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025